Disease areas
Disease areas
Lymphoma
.jpg?width=625&height=288&format=webp&quality=50)
Chronic Lymphocytic Leukemia
.jpg?width=625&height=288&format=webp&quality=50)
Waldenström macroglobulinemia
.jpg?width=625&height=288&format=webp&quality=50)
Mantelcellymfoom
Myeloid Leukemia
.jpg?width=625&height=288&format=webp&quality=50)
Myeloid Leukemia
Product portfolio in hematology
.png?width=544&height=250&format=webp&quality=50)
Imbruvica®
Imbruvica (ibrutinib) is a Bruton tyrosine kinase (BTK) inhibitor for the treatment of chronic lymphocytic leukaemia (CLL), mantle cell lymphoma (MCL) and Waldenström macroglobulinemia (WM). Discover scientific information, materials for you and your patients, therapy management and much more.
.png?width=544&height=250&format=webp&quality=50)
Darzalex®
Darzalex (daratumumab) is a targeted monoclonal antibody for the treatment of multiple myeloma (MM). Discover scientific information, materials for you and your patients, guidelines and much more.
CP-217996 March 2021
